Hollestelle MJ - Search Results

1

Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitution.

Bril WS, van Helden PM, Hausl C, Zuurveld MG, Ahmad RU, Hollestelle MJ, Reitsma PH, Fijnvandraat K, van Lier RA, Schwarz HP, Mertens K, Reipert BM, Voorberg J. Bril WS, et al. Among authors: hollestelle mj. Thromb Haemost. 2006 Feb;95(2):341-7. doi: 10.1160/TH05-08-0559. Thromb Haemost. 2006. PMID: 16493498

2

Factor VIII expression in liver disease.

Hollestelle MJ, Geertzen HG, Straatsburg IH, van Gulik TM, van Mourik JA. Hollestelle MJ, et al. Thromb Haemost. 2004 Feb;91(2):267-75. doi: 10.1160/TH03-05-0310. Thromb Haemost. 2004. PMID: 14961153

3

Tissue distribution of factor VIII gene expression in vivo--a closer look.

Hollestelle MJ, Thinnes T, Crain K, Stiko A, Kruijt JK, van Berkel TJ, Loskutoff DJ, van Mourik JA. Hollestelle MJ, et al. Thromb Haemost. 2001 Sep;86(3):855-61. Thromb Haemost. 2001. PMID: 11583319

4

Extra-hepatic factor VIII expression in porcine fulminant hepatic failure.

Hollestelle MJ, Poyck PP, Hollestelle JM, Marsman HA, Mourik JA, Gulik TM. Hollestelle MJ, et al. Among authors: hollestelle jm. J Thromb Haemost. 2005 Oct;3(10):2274-80. doi: 10.1111/j.1538-7836.2005.01543.x. Epub 2005 Sep 7. J Thromb Haemost. 2005. PMID: 16150043 Free article.

5

Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease.

van der Land V, Mutsaerts HJ, Engelen M, Heijboer H, Roest M, Hollestelle MJ, Kuijpers TW, Nederkoorn PJ, Cnossen MH, Majoie CB, Nederveen AJ, Fijnvandraat K. van der Land V, et al. Among authors: hollestelle mj. Br J Haematol. 2016 Jan;172(2):274-84. doi: 10.1111/bjh.13819. Epub 2015 Oct 22. Br J Haematol. 2016. PMID: 26492630 Free article.

6

Cysteine-mutations in von Willebrand factor associated with increased clearance.

Schooten CJ, Tjernberg P, Westein E, Terraube V, Castaman G, Mourik JA, Hollestelle MJ, Vos HL, Bertina RM, Berg HM, Eikenboom JC, Lenting PJ, Denis CV. Schooten CJ, et al. Among authors: hollestelle mj. J Thromb Haemost. 2005 Oct;3(10):2228-37. doi: 10.1111/j.1538-7836.2005.01571.x. J Thromb Haemost. 2005. PMID: 16194200 Free article.

7

von Willebrand factor activation, granzyme-B and thrombocytopenia in meningococcal disease.

Hollestelle MJ, Sprong T, Bovenschen N, de Mast Q, van der Ven AJ, Joosten LA, Neeleman C, Hyseni A, Lenting PJ, de Groot PG, van Deuren M. Hollestelle MJ, et al. J Thromb Haemost. 2010 May;8(5):1098-106. doi: 10.1111/j.1538-7836.2010.03811.x. Epub 2010 Feb 16. J Thromb Haemost. 2010. PMID: 20158601 Free article.

8

Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients.

Hollestelle MJ, Loots CM, Squizzato A, Renné T, Bouma BJ, de Groot PG, Lenting PJ, Meijers JC, Gerdes VE. Hollestelle MJ, et al. J Thromb Haemost. 2011 May;9(5):953-8. doi: 10.1111/j.1538-7836.2011.04247.x. J Thromb Haemost. 2011. PMID: 21352469 Free article.

9

von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation.

Hollestelle MJ, Donkor C, Mantey EA, Chakravorty SJ, Craig A, Akoto AO, O'Donnell J, van Mourik JA, Bunn J. Hollestelle MJ, et al. Br J Haematol. 2006 Jun;133(5):562-9. doi: 10.1111/j.1365-2141.2006.06067.x. Br J Haematol. 2006. PMID: 16681646 Free article.

10

von Willebrand activation factor as a marker of mortality, cardiovascular events, and bleeding complications in patients treated with oral anticoagulants.

Lind M, Johansson L, Nilsson TK, Jansson JH, Hollestelle MJ. Lind M, et al. Among authors: hollestelle mj. Thromb Res. 2015 Nov;136(5):878-82. doi: 10.1016/j.thromres.2015.08.016. Epub 2015 Aug 28. Thromb Res. 2015. PMID: 26364970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page